Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Startup Investors in France in January 2026

Last updated: Jan 2026 A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in France. We rank investors based on the number of investments they made in Medical companies from France. We update this investor list every month.

Top 50 Medical Startup Investors in France in January 2026

Investor	Medical France investments
Bpifrance	48
Kurma Partners	15
Karista	13
Idinvest Partners	12
Sofinnova Partners	11
GO CAPITAL	10
Seventure Partners	8
Sofimac Investment Managers	8
LBO France	7
Octalfa	7
Auriga Partners	7
XAnge	7
KREAXI	7
Angels Santé	7
BNP Paribas Développement	6
Crédit Agricole	6
M Capital Partners	6
IRDI SORIDEC Gestion	5
Isai	5
Sham Innovation Santé	5
MACSF	4
Crédit Mutuel Innovation	4
Extens	4
IRDI	4
Pays de la Loire Participations	4
iBionext	4
Innovacom	4
Elaia	4
Kerala Ventures	4
Kima Ventures	4
Cap Innov'Est	4
Newfund	3
WiSEED	3
Bernard Majoie	3
Turenne Capital	3
Banque des Territoires	3
Citizen Capital	3
Sodero Gestion	3
Rhone-Alpes Creation	3
CEA Investissement	3
Normandie Participations	3
Serena	3
Paris-Saclay Seed Fund	3
Bpifrance Digital Venture	3
Omnes Capital	3
Supernova Invest	3
ODYSSEE VENTURE	3
Ventech	3
SOSV	3
Galia Gestion	3

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
France, United States, Switzerland

Portfolio highlights

AUSTRAL Dx — AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs. The company was founded in 2021 and is based in Paris.
IsentroniQ — Isentroniq solves the critical cryogenic power and space bottleneck in quantum computing. Our dense, near-heatless wiring solution unlocks 1000x more qubits.
Brevo — Brevo is a developer of a cloud-based digital marketing platform used to meet the demand of businesses to engage with customers. Its platform encompasses the entire chain, from the creation of a newsletter to analysis and reporting tools to targeting modules that enable businesses, eCommerce sellers, and agencies to build customer relationshipsthrough digital marketing campaigns, transactional messaging, and marketing automation.Unlike other marketing solutions built for enterprise-level budgets and expertise, Sendinblue tailors its all-in-one suite to suit the marketing needs of growing SMBs in tough markets.The company was founded in 2012 and is headquartered in Paris, France.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Seed, Series B
France, Switzerland, Spain

Portfolio highlights

DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Series B
France, United States, Finland

Portfolio highlights

CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Funding Round
France, United States, Spain

Portfolio highlights

Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Excelsior Sciences — Rebuilding the World, From the Bottom Up

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France, Canada, Israel

Portfolio highlights

AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
Reelevant — Only 1 out of 10 people interact with marketing messages. Content is the bottleneck of personalization, not data. Personalization doesn't work because data are used to create targeted campaigns. Data must be used to create content because content creates interactions and drive conversion.Why: create content for people, not for campaigns(visual is the key to emotions) How: on-demand, when the user request, at the opening/reading/exposure (Pull content vs Push marketing) What: end-to-end widgets solutions like Live content, Individualization, Content Automation, Optimization, etc.Our visual content platform accelerates revenue, creates content based on any data (behavioral, contextual, etc.) created on the fly at the moment of exposure (on any channel (email, web, push notifications, in-app messages, etc.). We take advantage of existing data sources, nothing to create, we supercharge your marketing stack. Our data-driven Content Engine translates data from any source into on-demand visual content in milliseconds for each people.We believe in a new way of thinking about messages by shifting the paradigm of push marketing to transform any data into on-demand visual content. One unique content is created for each people on the fly at the moment people decide to read them (pull content), instead of when marketers decide to create them (push marketing).People are not data points, people don't buy products, they buy emotions. On-demand visual content is the new game!

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Investment focus

Biotechnology, Health Care, Software
Series A, Funding Round, Series B
France, United States, Germany

Portfolio highlights

Sentryc — Protect your brand and your products from counterfeiters with Sentryc. We monitor over 120 marketplaces for you and remove potential counterfeits.
Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
Hepster — hepster, die Onlineversicherung, flexibel, sicher und immer 100% digital.

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
France, Italy, Austria

Portfolio highlights

Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

A pioneer in private equity in France, LBO France is now a leading multi-specialist, multi-country investment platform.

Investment focus

Health Care, Medical, Software
Series A, Series B, Funding Round
France, Spain, Luxembourg

Portfolio highlights

Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Octalfa is a France-based venture capital firm that offers a range of financial services.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Seed, Series A
France

Portfolio highlights

Mathym — Mathym - a nanotechnology company dedicated to the development, manufacturing and commercialization of nanomaterials and nanodispersions.
ORPHELIA Pharma — ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus ondeveloping optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.
Sirius NeoSight — Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
France, United States, Switzerland

Portfolio highlights

Amplitude — Amplitude is a leading manufacturer of femtosecond lasers. We are laying the foundations for advances in science, industry, and health care.
Pherecydes Pharma — Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
Median Technologies — We harness the power of Imaging Phenomics to contribute to the development of next generation treatments and care strategies for patients in need.

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Investment focus

Software, Information Technology, SaaS
Series A, Seed, Series B
France, Germany, Belgium

Portfolio highlights

Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
Diagnoly — Diagnoly provides AI-powered ultrasound assistant that enhances fetal screenings with real-time analysis, instant insights, and zero workflow disruption.

Kreaxi is a management company specializing for over 30 years in investing in the capital of innovative and technological startups with high potential.

Investment focus

Software, Information Technology, SaaS
Seed, Funding Round, Series A
France, Italy, Switzerland

Portfolio highlights

QiOVA — Founded in 2011, QiOVA develops and markets the world's fastest laser marking and micromachining solutions thanks to the pioneering integration of programmable multibeam technology.
B2eBike — B2ebike provides comprehensive electric bicycle fleet (VAE) solutions for businesses and communities. The best strategy to convert to a soft form of transportation.
Diamfab — Diamond semiconductor - DIAMFAB - Our project aims to manufacture a sustainable carbon-based diamond semiconductor !

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Investment focus

Health Care, Biotechnology, Medical Device
Seed, Funding Round, Angel
France, India, United States

Portfolio highlights

Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
Odimma — Empowering personalized immunotherapy to treat cancer
AUSTRAL Dx — AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs. The company was founded in 2021 and is based in Paris.

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Seed
France, Germany, The Netherlands

Portfolio highlights

DESKi — HeartFocus is an AI-powered heart exam software for ultrasound and can be used with any hand-held probe, cart or ultrasound system. The product is available as an APP or SDK and is appropriate for clinics, health systems and learning institutions
Skyld — Skyld create AI-powered security solutions The goal of our endeavor is to prevent reverse engineering and model theft. It is not possible to solve these issues with patents. A true "anti-theft" solution for AI models is what we are creating.
Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Investment focus

Software, Manufacturing, Health Care
Funding Round, Seed, Debt Financing
France, United States, Italy

Portfolio highlights

Mowi — Home - Mowi Company Website
Eduservices — Eduservices network and pool a set of skills and resources for schools.
FlowPay — Open banking & payment solutions. FlowPay supporta la tua azienda nei flussi di incasso e pagamento con soluzioni innovative integrabili via API.

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Investment focus

Health Care, Software, Food and Beverage
Funding Round, Seed, Series A
France, United States, Canada

Portfolio highlights

Fasst — Fasst is involved in the creation, distribution, consulting, and connection of unique digital insurance solutions for brokers and insurers.
Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Investment focus

Software, Biotechnology, Manufacturing
Seed, Series A, Funding Round
France, Brazil, Singapore

Portfolio highlights

bYoRNA — bYoRNA is a French biotechnology company specializing in the cost-efficient, scalable bioproduction of high-quality therapeutic messenger RNA (mRNA) using engineered eukaryotic cells, particularly recombinant yeast. Their disruptive platform enables the production of long, humanized mRNA with lower immunogenicity and higher integrity compared totraditional in vitro enzymatic synthesis. This technology aims to mass produce mRNA for gene therapies, cancer vaccines, and infectious disease vaccines at a fraction of current costs, making mRNA therapeutics more accessible globally.
FEEDAE — Feedae uses AI-augmented dialog analysis to boost sales and customer service teams' performance.
Greenphage — Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions tosupport its phage therapy efforts.

Isai is a tech entrepreneurs' fund that focuses on early-stage internet startups and small capital tech private equity deals. It seeks to invest in companies operating in the software, information technology, media, and industrial sectors. It brings together more than 300 tech entrepreneurs who have decided to invest their money and theirexperience in order to allow the emergence of new French Tech champions.Founded in 2010, Isai is headquartered in Paris, France.

Investment focus

Software, Information Technology, Internet
Series A, Seed, Series B
France, United States, Austria

Portfolio highlights

Carbyon — Carbyon is a Netherlands-based company that develops direct air capture (DAC) technologies. The company's fuels help to replace fossil hydrocarbons with electrical batteries or hydrogen (H2), alternative energy carriers that are used to store renewable electricity and make major changes to transportation facilities, energy grids, and gastransportation networks, filters CO2 from the air and supply it in a purified form to make kerosene for aircraft, enabling existing fossil industry to re-use and repurpose these storage and transport facilities for renewable hydrocarbons.
Flowdesk — The new standard for market-making and crypto-financial technology. Market-making as a Service, brokerage, custody of cryptocurrencies.
Inicio — Inicio's objective is to expedite the energy transition of territories by lowering the risk of establishing solar projects and encouraging collaborations between landowners and renewable energy project developers.

Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

Investment focus

Biotechnology, Medical Device, Medical
Series B, Series A, Funding Round
France

Portfolio highlights

Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.

Investment focus

Health Care, Artificial Intelligence, Medical Device
Series A, Funding Round, Seed
France, Spain, Ecuador

Portfolio highlights

Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
Singulier — Singulier partners with global private equity funds and portfolio companies from due diligence to transformation.
RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Series A, Series B
France, United States, Canada

Portfolio highlights

Obat — Obat is a saas solution provider that uses software for contractors and self-employed for invoicing.
Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Glopal — Glopal provides advanced international Google shopping solutions for ecommerce retailers and brands seeking to grow their businesses' globally.

Extens believes that the healthcare industry is undergoing profound transformation and that information and communication technologies (ICTs) will gradually bring about, and today, considerable improvements. E-health will contribute to the transformation of health pathways by improving the performance of care, allowing a better quality of life atall stages of life and reducing the inefficiencies of our health systems.

Investment focus

Medical, Health Care, Apps
Funding Round, Private Equity
France

Portfolio highlights

Kayentis — Since 2005, Kayentis has supported pharma, biotechs, and CROs by capturing meaningful patient input. With user-friendly eCOA technology and top-quality services, we ensure high quality datasets and improve the experiences of patients and sites. Challenge your eCOA vendor and embark on a seamless eCOA clinical trial experience with us!
Keenturtle — Keenturtle is a medtech that provides e-health solutions to enhance medical & economic field such as provision of health data.
DigitecPharma — DigitecPharma is a SaaS powered mobile application platform for patient relationship management for pharmaceutical dispensaries.

IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.

Investment focus

Health Care, Biotechnology, Software
Funding Round, Series A, Series B
France

Portfolio highlights

REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.

Pays de la Loire Participations provides finance innovation, productivity and development, especially in a banking context that is increasingly constrained by standards and regulations.The Pays de la Loire region has created the "Pays de la Loire Participations" co-investment fund (PLP) intended for small and medium-sized companieswishing to strengthen their equity. By investing alongside private professional investors, it facilitates risk taking and helps anchor long-term skills on the territory and promotes job creation and wealth.With 14 million euros in capital (20 million in the long term), entirely contributed by the Region, the "Pays de la Loire Participations" fund co-invested an average of around 2.5 million euros annually. average of € 180 K per company. Its intervention as a co-investor is crucial because it allows the VSE / SME beneficiaries to obtain from private financiers and banks, 4 times the funds contributed by Pays de la Loire participations.

Investment focus

Manufacturing, Software, E-Commerce
Funding Round, Seed, Private Equity
France

Portfolio highlights

VoltR — VoltR is a manufacturing company specializes in restoring lithium batteries.
Tract'Moi — Tract'Moi is a producer of farming equipment for farmers seeking independence and adaptability.
D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.

iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.

Investment focus

Medical Device, Artificial Intelligence, Biotechnology
Funding Round, Series A, Seed
France

Portfolio highlights

Prophesee — REVEAL THE INVISIBLE with the world's most advanced neuromorphic vision system, inspired by human vision and built on the foundation of neuromorphic engineering. PROPHESEE gives Metavision to machines, revealing what was previously invisible to them.
GrAI Matter Labs — GrAI Matter Labs has created the fastest edge AI processor for machine vision in robotics, AR/VR, drones and more. It achieves ultra-low latency at low power by leveraging sparsity.
Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.

Innovacom provides new technologies, hardware, and software products. They focus on the creation of financial and strategic value through support, networking, and the search for the best industrial partners for our startups in a context of open innovation.

Investment focus

Software, Mobile, Telecommunications
Funding Round, Series B, Series A
France, United States, Canada

Portfolio highlights

Interactive Autonomous DYnamic Systems — Iadys designs robotic and AI solutions like the Jellyfishbot for environmental preservation and oil spill response.
ION-X — Based on patented technology, our unique ionic liquid electrospray thrusters is the next big thing in small satellites propulsion.
AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Series B
France, United States, Spain

Portfolio highlights

Pili — PiLi biofabricates a sustainable alternative to create renewable inks to replace their toxic, non-biological, and non-recyclable versions.Pili was born from the reunion of a biologist, a designer, and a financial analyst at the biohacker space La Paillasse in Paris and with the creation of the first pen fed by bacteria. Its team is nowdedicated to providing the colors from micro-organisms to offer a sustainable alternative to fossil resources.
Djust — DJUST is the dedicated solution that helps companies launch their B2B eCommerce and eProcurement platforms faster
SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.

French VC fund insanely focused on bringing massive strategic and operational support to its entrepreneurs.

Investment focus

Internet, SaaS, Software
Seed, Series A, Funding Round
France

Portfolio highlights

Lokki — Lokki is a software tool for equipment rental companies.
Skillup — Skillup has designed the new @Tripadvisor for professional trainings hosting over 20k trainings and 50k reviews. It aims at helping HR services to find the adequate trainig for employees.
Napta — PickYourSkills is a SaaS solution helping companies to find the best match between their projects and their employees.

Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.

Investment focus

Software, SaaS, Information Technology
Seed, Pre-Seed, Series A
France, United States, United Kingdom

Portfolio highlights

Mokn — Phish-back your credentials from attackers using contextualized deceptive technology.
IsentroniQ — Isentroniq solves the critical cryogenic power and space bottleneck in quantum computing. Our dense, near-heatless wiring solution unlocks 1000x more qubits.
Motley — Manual reporting costs business teams 2.4 billion hours a year. Get your time back with Motley, your AI reporting assistant.

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Investment focus

Biotechnology, Pharmaceutical, Health Care
Seed, Series A, Funding Round
France, United States

Portfolio highlights

VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
Opencell Software — Opencell was created in 2015 to leverage an open source telco billing project initiated in 2007 by David Meyer, their current CEO.Their mission is to provide the first agile monetization platform capable of filling the gap between costly and complex legacy billing solutions and the overly simplistic “one size fits all” SaaS solutions that coveronly the most basic requirements.Opencell is now the open source monetization and billing platform with over 40 successful implementations in multiple industries and countries.
Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.

Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.

Investment focus

Software, Information Technology, SaaS
Seed, Funding Round, Series A
France, United States, Canada

Portfolio highlights

Omnidoc — Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
Raidium — Radiology augmented GPT to tackle the complexity of precision medicine
Arenametrix — Arenametrix is the first Customer Data Platform dedicated to entertainment.

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Investment focus

Software, Manufacturing, Biotechnology
Seed, Funding Round, Equity Crowdfunding
France

Portfolio highlights

Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.

Bernard Majoie - President @ Fournier-Majoie

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Series A
France, Belgium

Portfolio highlights

reMYND — Driving the development of disease-modifying treatments
AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology

Turenne Capital is an independant private equity management company, with 4 offices in France : - Paris - Lyon - Marseilles - Lille (joint-venture). Since 1999, Turenne Capital has been taking significant minority or majority equity stakes alongside entrepreneurs who operate SMEs with revenues ranging from €5 million to € 100 million. Itinvests between €1 million and €10 million per transaction. Turenne Capital manages/advises more than € 500 million. 32 people, among which 21 investors work in the Group. ------------------------------------------------------------------------------ Turenne Capital est une Société de gestion indépendante spécialisée en capital investissement. Turenne Capital accompagne depuis 1999 des entrepreneurs dans leur développement et la transmission de leur société et est implantée à : - Paris - Lyon - Marseille - Lille (filiale) Les tickets d'investissement vont de '1 à 10 millions d'euros en minoritaire et majoritaire dans des PME de 5 à 100 M€ de Chiffre d'affaires. Le Groupe Turenne Capital compte 32 professionnels dont 21 investisseurs, et gère/conseille plus de 500 M€ confiés par des institutionnels et des particuliers.

Investment focus

Software, Biotechnology, Medical Device
Funding Round, Series A, Private Equity
France, Poland, Germany

Portfolio highlights

Sydev — Sydev is a publisher of management software and tariff databases for technical building trades in the construction industry.
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.

Banque des Territoires is a Investment Firm.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
France, United States

Portfolio highlights

Kapsera — Kapsera bridges the gap between sustainability and productivity in agriculture, using cutting-edge, biosourced and biodegradable formulation technologies.Kapsera offers natural and innovative formulations for microbials based biofertilizers and biopesticides.
Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
Leakmited — At leakmited they reduce Non Revenue Water by finding leaks and by predicting risky pipes.They collect the client's Geographical Information System providing locations of the infrastructure and the history of breakdowns and leakages.

Citizen Capital is a leading French private equity fund dedicated to using an impact-driven investment approach to deliver both financial and social returns for investors and society at-large. Citizen Capital manages €60 million and provides growth capital to high growth small or medium companies (€1 to 50 million sales) with a strong socialpurpose targeting :- Inclusion : adress the needs of underserved populations (silver economy, health, education, Bottom of the Pyramid...)- Social mobility : enable excluded people to access employment and cross social barriers (job creation in underserved areas, integration of disabled or low-educated workers...)- Sustainable production and consumption : change consumption habits and give access to sustainable goods and services (local production and short distribution channels, environment-driven technologies...)- Social Innovation : introduce new organisation models with tangible positive impact upon employees and partners (employee shareholding schemes, collaborative management...)Our goal is to build wealth for all stakeholders in our portfolio companies. In addition to capital we offer a combination of strategic, financial, operational guidance to the companies in which we invest, as well as a pro-active support in building and driving impact strategy – Citizen Capital has implemented a methodology combining social impact and ESG approach. Citizen Capital has signed the Principles for Responsible Investment (United Nations, PRI) and is a member of the G8 Social Impact Investment Task Force.

Investment focus

Health Care, Software, Information Technology
Series A, Funding Round, Seed
France, United States, Germany

Portfolio highlights

Hubcycle — Hubcycle turns food by-products into high-performance ingredients. Scalable, traceable solutions for industries committed to sustainable sourcing.
CardioParc — CardioParc is a network of cardiology institutions that aims to redefine cardiology consulting by reorganizing it around the notion of delegation of tasks.
Phagos — Phagos uses AI and phages to create personalized bacterial treatments in 2 months. Our sustainable antibiotic alternative targets specific bacteria without resistance, serving chicken, cattle, swine, and shrimp farms worldwide.

Sodero Management has 70 million of capital it intends to finance for SMEs. These funds come from the Caisse d'Epargne and Caisse des Depots et Consignations, firstly, of Brittany and Pays de la Loire, on the other. But also individuals from which â‚¬ 26m was raised in 5 years through FIP (Local Investment Fund sold each year by the SavingsBank from November). And local savings will directly feed the local economy while enjoying immediate tax benefits.

Investment focus

Software, Information Technology, Telecommunications
Seed, Funding Round, Series A
France

Portfolio highlights

Grimp — Saas solution to manage your job search in one place.
D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.
BioMAdvanced Diagnostics — Online138 menghadirkan festival terbesar yang didalamnya terdapat hiburan online tanpa batas dengan bekerja sama bersama GGSoft yang paten dan gampang menang hari ini.

Rhone-Alpes Creation is a venture capital firm that focuses on early-stage investments in software and biotechnology.

Investment focus

Environmental Engineering, Software, Manufacturing
Seed, Funding Round, Series A
France

Portfolio highlights

Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
CentrExpert — CentrExpert provides global safety solutions for training, material audit transformation of standard industrial equipment to make it usable in areas with certification and after-sales service. The company is committed to converting machines and equipment, enabling it to be used in explosive atmospheres, more commonly known as ATEX zones.CentrExpert was founded on 2011 and is headquartered in Chasse-sur-rhône, France.
APIX Analytics — APIX Analytics is a nano-silicon based chemical analysis for industrial, environmental, and security applications. The company focuses on the development of miniaturized multigas analyzers systems based on integration on silicon of analytical chains such as sampling, injection of gases, separation of complex gas mixtures to improve specificity anddetection, identification, and quantification of each mixture compound.APIX Analytics was founded on 2014 and is headquartered in Grenoble, France.

CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.

Investment focus

Manufacturing, Biotechnology, Energy
Seed, Series A, Funding Round
France, Canada, United States

Portfolio highlights

HEXANA — HEXANA is an energy platform that combines flexible sodium-cooled fast neutron reactors with a thermal management system.
STELLARIA — Stellaria is a 200 MWe molten salt reactor with 20-year autonomy, delivering safe, sustainable nuclear power without refueling.
STELLARIA — Stellaria is reimagining sustainable rapid neutron nuclear energy.

Normandie Participations is a venture capital fund that co-invests in companies based in Normandy. It invests through equity and quasi-equity in small and medium-sized enterprises. The firm was founded in 2016 and is based in Colombelles, France.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France

Portfolio highlights

RMAN Sync — RMAN Sync is the collaborative SRM by AI and deep learning that develops synergies between purchasing, supply chain, and trade.
Loop Dee Science — Loop Dee Science is a DNA startup that makes molecular biology diagnostics. They develop and manufacture field genetic analysis kits for the detection of pathogen DNA and RNA. Their automatic field analysis device is a multi-spectral analysis device that provides local output and can also be connected via USB or Bluetooth.
Good Motors agency — Good Motors agency offers self-service motorcycle rentals near train stations and airports in France's most beautiful regions.

Serena is one of Europe's leading venture capital funds, with $750m under management. Founded in 2008, Serena invests at early stages, from seed to series B, and supports the success of innovative and ambitious entrepreneurs to service a better world. Born of the profound conviction that a venture capital fund should be at the service of itsportfolio companies, Serena has set up the largest operational support team in Europe and the most active startup community, the Serena Squad, with more than 550 active C-levels. Serena has a strong focus on AI, SaaS, Climate Tech, Digital Transformation, and Impact. Serena has invested in more than 100 startups with several international success stories such as Dataiku, Malt, The Fork, Electra, Descartes Underwriting, Accenta, Lifen, and AramisAuto. Combating climate change, protecting biodiversity, promoting sustainability, diversity and inclusion are at the heart of Serena's DNA.

Investment focus

Software, Artificial Intelligence, Internet
Series A, Seed, Series B
France, United States, Switzerland

Portfolio highlights

Inato — Inato matches the right sites to the right clinical research study, globally.
Odaseva — Odaseva enterprise data security platform protects Salesforce data, ensures business continuity, and helps meet compliance requirements. Get a demo today.
Kili Technology — Kili Technology enables large companies to transform their raw data into high-quality annotated data, ready for AI-driven projects.

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Investment focus

Health Care, Medical, Fitness
Seed, Series B, Series A
France

Portfolio highlights

FeetMe — FeetMe is a medical company. Loss of mobility is a growing unmet medical need, 100 million people are suffering from mobility disorders worldwide. FeetMe has a mission to simplify and accelerate therapeutic and rehabilitation evaluations through continuous real life mobility assessment. FeetMe Monitor is a connected insole and an associated mobilesoftware that collects and analyze gait spatio-temporal parameters and variability in real life thanks to embedded smart algorithms and wireless connection. Their solution is sold to pharma companies for clinical trials, or to hospital and rehabilitation centers for mobility assessment and gait training and to patients for home rehabilitation.
Sensome — Sensome develops a breakthrough remote monitoring technology that can turn invasive vascular medical devices into connected healthcare devices. By providing ins
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Bpifrance Digital Venture operates as a venture capital firm.

Investment focus

Health Care, Artificial Intelligence, SaaS
Series A, Seed, Pre-Seed
France

Portfolio highlights

Edflex — Edflex est une solution SaaS qui connecte les entreprises avec les meilleurs contenus de formation (MOOC, vidéos, podcasts, articles…).
Chipiron — At Chipiron, we are on a mission to end cancer through scalable MRI technologies. We are building the first light, inexpensive, and open full-body MRI machine that doesn't compromise image quality.
altrove AI — Altrove - Sustainable Alternatives to Critical Materials

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Investment focus

Biotechnology, Software, Health Care
Series A, Funding Round, Series B
France, Germany, United States

Portfolio highlights

Caracol — Lead the future of manufacturing thanks to Caracol's 3D printing technologies. Discover our solutions for industrial, Large Format Additive Manufacturing.
Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Amakem — Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique â€˜Localized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducingside effects.

we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.

Investment focus

Health Care, Manufacturing, Medical Device
Series A, Funding Round, Series B
France, Israel, Denmark

Portfolio highlights

Traxens — TRAXENS delivers the world's most exhaustive, precise and timely information on containers and container transporters allowing all stakeholders in multi-modal transport to improve costs, optimize investment, and offer premium services.To attain this performance TRAXENS led a 3-year R&D program to develop specific technology required toproduce cost effective, durable and autonomous devices for a wide range of container data capture and real-time transmission of this data from anywhere on the globe.
CrowdSec — CrowdSec is an open-source and collaborative security stack leveraging the crowd power. Analyze behaviors, respond to attacks & share signals across the community. Join the community and le's make the Internet safer, together.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.

ODYSSEE VENTURE is a French Venture Capital and Private Equity firm. It was founded by Mathieu Boillet and Sébastien Sassolas in 1999 and is based in Paris, France. The company has raised over 600M€.

Investment focus

Software, Information Technology, Analytics
Funding Round, Series A, Private Equity
France, United States

Portfolio highlights

Copains — Copains is a bakery that produces a wide variety of pastry and confectionery items intended to offer a healthy eating approach.
Terratis — Terratis is a French company that uses the Sterile Insect Technique (SIT) to reduce the populations of tiger mosquitoes and agricultural pests. Their mission is to diminish harmful insect populations effectively on a large scale using a scientific, innovative, ecological, and efficient approach.
Circle Safe — Atrial fibrillation is the most common cardiac arrhythmia. The most effective way to prevent recurrence is to perform an interventional procedure: ablation. Most of these procedures are performed by Radiofrequency or by a more recent technique, the Cryoballoon. The latter has many advantages including speed and simplicity but has a complicationthat is specific to it: the risk of creating Diaphragmatic Paralysis. Circle Safe is developing a solution with the aim of permanently eliminating this complication.

On-the-ground expert investors in early-stage digital. Ready to meet you, wherever you are.

Investment focus

Software, E-Commerce, Information Technology
Series A, Series B, Seed
France, Germany, United States

Portfolio highlights

DRIMCo — DRIMCo is an enterprise AI-SaaS product to analyze requirements in documents and optimize business processes.
Olyzon — Olyzon offers adtech solutions for Connected TV, enhancing brand uplift, optimizing user engagement, and maximizing ROI for advertisers, content owners, and distributors.
Inven — Save time by using AI to find companies. Inven scans millions of websites to provide comprehensive data on companies similar to your search criteria.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Investment focus

Software, Manufacturing, Biotechnology
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Investors by industry

Community

Artificial intelligence